REFERENCES
- Heney NM. Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 1992; 3: 429-33.
- Seddighzadeh M. Stenieck G, Jansson O, Larsson P, Wijkström H, Adolfsson J, et al. Low interleukin-l-alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. Br J Cancer 2001; 84: 329-34.
- Bergren P. Steineck G, Adolfsson J, Hansson J, Jansson O. Larsson P. et al. P53 mutations in urinary bladder cancer. Br J Cancer 2001; 84: 1505-11.
- Wijkström H. Steineck G. Bladder cancer, diagnosis, treatment and follow-up. Regional treatment programme. Stockholm: Oncology Centre, 1995 (in Swedish).
- Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-8.
- Carbin BE, Ekman P, Gustafsson H, Christensen NJ, Sandstedt B. Silfversward C. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. J Urol 1991; 145: 968-71.
- Mostofi FK, Davies CJ, Sesterhenn IA. Histological typing of urinary bladder tumours. International classification of tumours, No. 10.2nd edn. Geneva, Switzerland: WHO. 1999.
- International Union Against Cancer. TNM classification of malignant tumours, 3rd edn. Geneva, Switzerland: WHO. 1978.
- Holmäng S, Hedelin H, Anderstrom C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low-grade papillary urothelial tumors. J Urol 1999; 162; 702-7.
- Malmström PU, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer. A retrospective study of 232 patients with >5 years follow-up. Scand J Urol Nephrol 1987; 21; 185-95.
- Zieger K, Wolf H. Olsen PR, Hojgaard K. Long-term survival of patients with bladder tumours: the significance of risk factors. Br J Urol 1998; 82: 667-72.
- Anderström C, Johansson S, Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Urol 1980; 124: 23-6.
- Parmar MK, Freedman LS, Hargreave TB, Tolley DA. Prognostic factors for recurrence and follow-up policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer. J Urol 1989; 142: 284-8.
- Holmäng S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. Prospective registration of all patients in a geographical region with new diagnosed bladder carcinomas during a two-year period. Scand J Urol Nephrol 2000; 34:95-101.
- Holmäng S, Andius P, Hedelin H, Wester K, Busch C, Johansson SL. Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohisto-chemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol 2001; 165: 1124-8.